Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Porphyrins as radiosensitizing agents for solid neoplasms.

M Schaffer1, B Ertl-Wagner, P M Schaffer

  • 1Dept. of Radiation Therapy and Radiation Oncology, University of Munich, Germany. mschaffe@helios.med.uni-muenchen.de

Current Pharmaceutical Design
|October 8, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decreased Craniocervical CSF Flow in Patients with Normal Pressure Hydrocephalus: A Pilot Study.

AJNR. American journal of neuroradiology·2022
Same author

Animal tissue-based quantitative comparison of dual-energy CT to SPR conversion methods using high-resolution gel dosimetry.

Physics in medicine and biology·2020
Same author

VOLT: a novel open-source pipeline for automatic segmentation of endolymphatic space in inner ear MRI.

Journal of neurology·2020
Same author

[Magnetic resonance imaging of the brain in neonates and infants].

Der Radiologe·2019
Same author

A probabilistic atlas of the human inner ear's bony labyrinth enables reliable atlas-based segmentation of the total fluid space.

Journal of neurology·2019
Same author

Running effects on cognition and plasticity (ReCaP): study protocol of a longitudinal examination of multimodal adaptations of marathon running.

Research in sports medicine (Print)·2019

This study reviews a novel method using Photofrin II to selectively enhance radiation therapy effects on solid tumors, particularly radioresistant, hypoxic cells. This approach aims to maximize tumor cell kill while minimizing damage to healthy tissues.

Area of Science:

  • Oncology
  • Radiation Biology
  • Photodynamic Therapy

Background:

  • Radiation therapy's biological effects vary based on tissue type and biological parameters.
  • Current radiosensitizers lack tumor specificity, impacting normal tissues.
  • Targeting radioresistant and hypoxic tumor cells remains a challenge in radiation oncology.

Purpose of the Study:

  • To review a new, selective modality for enhancing radiation sensitivity in solid tumors.
  • To highlight the potential of Photofrin II in improving radiation therapy outcomes.
  • To focus on increasing the efficacy of radiation against radioresistant, hypoxic tumor cells.

Main Methods:

  • Review of a selective and specific modality for radiation sensitization.
  • Application of Photofrin II, a known photosensitizer in photodynamic therapy (PDT).

Related Experiment Videos

  • Administration of Photofrin II prior to therapeutic irradiation.

    • Main Results:

    • Photofrin II demonstrates potential as a selective radiosensitizer.
    • The modality specifically targets radioresistant, hypoxic tumor cells.
    • Early clinical evaluation suggests promise for this novel approach.

    Conclusions:

    • Photofrin II offers a selective and specific method to enhance tumor radiosensitivity.
    • This approach holds promise for improving cancer treatment by targeting resistant cells.
    • Further clinical evaluation is ongoing for this innovative radiation therapy strategy.